✦ LIBER ✦

Improvement of cognitive function in Alzheimer’s disease model mice by genetic and pharmacological inhibition of the EP4 receptor

✍ Scribed by Tatsuya Hoshino; Takushi Namba; Masaya Takehara; Naoya Murao; Takahide Matsushima; Yukihiko Sugimoto; Shuh Narumiya; Toshiharu Suzuki; Tohru Mizushima

Book ID: 111184755
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 766 KB
Volume: 120
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2011.07567.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-mnestic cognitive function in the sc

Non-mnestic cognitive function in the scopolamine model of Alzheimer's Disease

✍ Marc C. Obonsawin; Anne Robertson; John R. Crawford; Chris Perera; Shona Walker; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

The contribution of cholinergic dysfunction to the non-mnestic cognitive impairments associated with senile dementia of the Alzheimer type (SDAT) was investigated. Scopolamine (0 . 5 mg) was administered intravenously to 12 healthy individuals, and their performance on selected subtests of the Wechs

Improvement of memory deficits by diosge

Improvement of memory deficits by diosgenin in Alzheimer's disease model mice and the molecular mechanism underlying the effect

✍ Takuya Urano; Chihiro Tohda 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Ciproxifan, an H3 receptor antagonist, a

Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APPTg2576 mouse model of Alzheimer’s disease

✍ Mark E. Bardgett; Natasha N. Davis; Patrick J. Schultheis; Molly S. Griffith 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 683 KB

Inhibition of plasminogen activator acti

Inhibition of plasminogen activator activity may be critical in the loss of cognitive function and amyloid-beta accumulation in Alzheimer's disease brain

✍ Nicholas Seeds; Shay Fabbro 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

THE ROLE OF TUMOR NECROSIS FACTOR-ALPHA

THE ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN COGNITIVE IMPROVEMENT AFTER PEROXISOME PROLIFERATOR-ACTIVATOR RECEPTOR GAMMA AGONIST PIOGLITAZONE TREATMENT IN ALZHEIMER'S DISEASE

✍ Haruo Hanyu; Tomohiko Sato; Hirofumi Sakurai; Toshihiko Iwamoto 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

3.242 INHIBITION OF MONOAMINE OXIDASE-B

3.242 INHIBITION OF MONOAMINE OXIDASE-B BY CURCUMIN AND TETRAHYDROCURCUMIN IN THE MICE MODEL OF PARKINSON'S DISEASE

✍ S. Sabesan Muthukumaran; A. Rajeswari 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB